Journal article

Comparison of Illumina and 454 Deep Sequencing in Participants Failing Raltegravir-Based Antiretroviral Therapy

Jonathan Z Li, Brad Chapman, Patrick Charlebois, Oliver Hofmann, Brian Weiner, Alyssa J Porter, Reshmi Samuel, Saran Vardhanabhuti, Lu Zheng, Joseph Eron, Babafemi Taiwo, Michael C Zody, Matthew R Henn, Daniel R Kuritzkes, Winston Hide

PLoS ONE | PUBLIC LIBRARY SCIENCE | Published : 2014

University of Melbourne Researchers

Grants

Awarded by National Institutes of Health (NIH)


Awarded by National Institutes of Health (NIH) (Statistical and Data Management Center of the AIDS Clinical Trials Group)


Awarded by National Institutes of Health (NIH) (AIDS Clinical Trials Group)


Awarded by National Institutes of Health (NIH) (ACTG Statistical and Data Management Center)


Awarded by Harvard Clinical and Translational Science Center


Awarded by NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES


Awarded by NATIONAL CENTER FOR RESEARCH RESOURCES


Awarded by NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES


Funding Acknowledgements

This work was supported in part by National Institutes of Health (NIH) grants K08 AI100699 (to Dr. Li), U01 AI068634 (Statistical and Data Management Center of the AIDS Clinical Trials Group), U01 AI068636 (AIDS Clinical Trials Group), U01 AI068634 (ACTG Statistical and Data Management Center), and a subcontract from U01 AI068636 to the Harvard Virology Support Laboratory (to Dr. Kuritzkes). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The TopCoder crowdsourcing competition was funded by the Harvard Clinical and Translational Science Center (UL1 RR 025758 and financial contributions from participating institutions).